{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:05:23Z","timestamp":1792098323744,"version":"4.4.0"},"reference-count":48,"publisher":"The Endocrine Society","issue":"4","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1210\/jc.2017-00283","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T14:01:32Z","timestamp":1516629692000},"page":"1302-1309","source":"Crossref","is-referenced-by-count":22,"title":["Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis"],"prefix":"10.1210","volume":"103","author":[{"given":"Fatma","family":"Gossiel","sequence":"first","affiliation":[{"name":"The Mellanby Centre for Bone Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R","family":"Scott","sequence":"additional","affiliation":[{"name":"The Mellanby Centre for Bone Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A","family":"Paggiosi","sequence":"additional","affiliation":[{"name":"The Mellanby Centre for Bone Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim E","family":"Naylor","sequence":"additional","affiliation":[{"name":"The Mellanby Centre for Bone Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene V","family":"McCloskey","sequence":"additional","affiliation":[{"name":"The Mellanby Centre for Bone Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola F A","family":"Peel","sequence":"additional","affiliation":[{"name":"Metabolic Bone Centre, Sheffield Teaching Hospitals National Health Service Foundation Trust, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S","family":"Walsh","sequence":"additional","affiliation":[{"name":"The Mellanby Centre for Bone Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Eastell","sequence":"additional","affiliation":[{"name":"The Mellanby Centre for Bone Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"issue":"15","key":"2019041118371705300_B1","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","article-title":"Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass","volume":"165","author":"McClung","year":"2005","journal-title":"Arch Intern Med"},{"key":"2019041118371705300_B2","first-page":"1244","article-title":"Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters","volume-title":"J Bone Miner Res","author":"Arlot","year":"2005"},{"key":"2019041118371705300_B3","first-page":"366","article-title":"A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide","volume-title":"J Bone Miner Res","author":"Lindsay","year":"2006"},{"key":"2019041118371705300_B4","first-page":"736","article-title":"Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT","volume-title":"J Bone Miner Res","author":"Hansen","year":"2013"},{"key":"2019041118371705300_B5","first-page":"1932","article-title":"Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure","volume-title":"J Bone Miner Res","author":"Jiang","year":"2003"},{"key":"2019041118371705300_B6","first-page":"1846","article-title":"Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study","volume-title":"J Bone Miner Res","author":"Dempster","year":"2001"},{"key":"2019041118371705300_B7","first-page":"495","article-title":"Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium","volume-title":"J Bone Miner Res","author":"Lindsay","year":"2007"},{"key":"2019041118371705300_B8","first-page":"1741","article-title":"Parathyroid hormone and periosteal bone expansion","volume-title":"J Bone Miner Res","author":"Parfitt","year":"2002"},{"key":"2019041118371705300_B9","first-page":"539","article-title":"Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis","volume-title":"J Bone Miner Res","author":"Zanchetta","year":"2003"},{"issue":"4","key":"2019041118371705300_B10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/jc.2015-4181","article-title":"Differential effects of teriparatide and denosumab on intact PTH and bone formation indices: AVA Osteoporosis study","volume":"101","author":"Dempster","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041118371705300_B11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bone.2013.11.011","article-title":"Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment","volume":"59","author":"Ma","year":"2014","journal-title":"Bone"},{"key":"2019041118371705300_B12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mce.2015.12.014","article-title":"Periostin action in bone","volume":"432","author":"Bonnet","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"51","key":"2019041118371705300_B13","doi-asserted-by":"crossref","first-page":"35939","DOI":"10.1074\/jbc.M109.060335","article-title":"The matricellular protein periostin is required for Sost inhibition and the anabolic response to mechanical loading and physical activity","volume":"284","author":"Bonnet","year":"2009","journal-title":"J Biol Chem"},{"issue":"17","key":"2019041118371705300_B14","doi-asserted-by":"crossref","first-page":"13294","DOI":"10.1074\/jbc.M109.088864","article-title":"Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase","volume":"285","author":"Maruhashi","year":"2010","journal-title":"J Biol Chem"},{"issue":"12","key":"2019041118371705300_B15","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1074\/jbc.M113.539882","article-title":"Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis","volume":"289","author":"Ghatak","year":"2014","journal-title":"J Biol Chem"},{"key":"2019041118371705300_B16","first-page":"465","article-title":"Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update","volume-title":"Virchows Arch","author":"Morra","year":"2011"},{"issue":"3","key":"2019041118371705300_B17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1152\/physiolgenomics.00078.2009","article-title":"Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease","volume":"39","author":"Tkatchenko","year":"2009","journal-title":"Physiol Genomics"},{"issue":"37","key":"2019041118371705300_B18","doi-asserted-by":"crossref","first-page":"15048","DOI":"10.1073\/pnas.1203085109","article-title":"Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin","volume":"109","author":"Bonnet","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041118371705300_B19","volume-title":"Periostin interacts with sclerostin and inhibits its antagonistic effect on Wnt signalling. International Bone & Mineral Society (IBMS) Davos Workshops","author":"Chan","year":"2008"},{"issue":"19","key":"2019041118371705300_B20","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1007\/s00018-011-0784-5","article-title":"Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell","volume":"68","author":"Kudo","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"2019041118371705300_B21","first-page":"594","article-title":"Periostin is a collagen associated bone matrix protein regulated by parathyroid hormone","volume-title":"J Int Soc Matrix Biol","author":"Fortunati","year":"2010"},{"issue":"4","key":"2019041118371705300_B22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bone.2009.06.020","article-title":"Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts","volume":"45","author":"Bianchi","year":"2009","journal-title":"Bone"},{"issue":"2","key":"2019041118371705300_B23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jcb.20438","article-title":"Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray","volume":"95","author":"Onyia","year":"2005","journal-title":"J Cell Biochem"},{"issue":"1","key":"2019041118371705300_B24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bone.2005.12.020","article-title":"Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism","volume":"39","author":"Reppe","year":"2006","journal-title":"Bone"},{"issue":"8","key":"2019041118371705300_B25","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1210\/en.2011-0049","article-title":"Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in Sost-deficient mice","volume":"152","author":"Robling","year":"2011","journal-title":"Endocrinology"},{"key":"2019041118371705300_B26","first-page":"3301","article-title":"Teriparatide and denosumab combination therapy and skeletal metabolism","volume-title":"Osteoporosis Int","author":"Idolazzi","year":"2016"},{"key":"2019041118371705300_B27","first-page":"1171","article-title":"Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women\u2014the six-month effect of risedronate and teriparatide","volume-title":"Osteoporosis Int","author":"Polyzos","year":"2012"},{"issue":"6","key":"2019041118371705300_B28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2265.2009.03728.x","article-title":"The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis","volume":"72","author":"Anastasilakis","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2019041118371705300_B29","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2010-2552","article-title":"The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1","volume":"96","author":"Gatti","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019041118371705300_B30","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","article-title":"Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women","volume":"95","author":"Drake","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041118371705300_B31","first-page":"145","article-title":"Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment","volume-title":"Horm Metab Res","author":"Anastasilakis","year":"2014"},{"issue":"7","key":"2019041118371705300_B32","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1210\/jc.2013-3893","article-title":"Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study","volume":"99","author":"Rousseau","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041118371705300_B33","doi-asserted-by":"crossref","first-page":"E1014","DOI":"10.1210\/jc.2015-1183","article-title":"Additive genetic effects on circulating periostin contribute to the heritability of bone microstructure","volume":"100","author":"Bonnet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041118371705300_B34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bone.2015.08.014","article-title":"Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: clinical evidence for the different effects of periostin depending on the skeletal site","volume":"81","author":"Kim","year":"2015","journal-title":"Bone"},{"key":"2019041118371705300_B35","doi-asserted-by":"crossref","unstructured":"Gadermaier E , TesarzM, SuciuAA, WallwitzJ, BergG, HimmlerG. Characterization of a sandwich ELISA for the quantification of all human periostin isoforms. Journal of clinical laboratory analysis. 2017.","DOI":"10.1002\/jcla.22252"},{"issue":"2","key":"2019041118371705300_B36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00223-013-9798-3","article-title":"Precision of high-resolution peripheral quantitative computed tomography measurement variables: influence of gender, examination site, and age","volume":"94","author":"Paggiosi","year":"2014","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"2019041118371705300_B37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bone.2009.07.091","article-title":"Rapid and robust response of biochemical markers of bone formation to teriparatide therapy","volume":"45","author":"Glover","year":"2009","journal-title":"Bone"},{"issue":"6","key":"2019041118371705300_B38","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jcb.20506","article-title":"Effects of parathyroid hormone on Wnt signaling pathway in bone","volume":"95","author":"Kulkarni","year":"2005","journal-title":"J Cell Biochem"},{"issue":"4","key":"2019041118371705300_B39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10735-007-9096-3","article-title":"Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone","volume":"38","author":"Silvestrini","year":"2007","journal-title":"J Mol Histol"},{"key":"2019041118371705300_B40","first-page":"1903","article-title":"Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures","volume-title":"J Bone Mineral Res","author":"Kakar","year":"2007"},{"issue":"2","key":"2019041118371705300_B41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0749-0690(02)00074-5","article-title":"The anabolic effects of parathyroid hormone therapy","volume":"19","author":"Rubin","year":"2003","journal-title":"Clin Geriatr Med"},{"key":"2019041118371705300_B42","first-page":"925","article-title":"Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal","volume-title":"J Bone Miner Res","author":"Cosman","year":"2001"},{"issue":"4","key":"2019041118371705300_B43","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1210\/jc.2009-1703","article-title":"Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis","volume":"95","author":"Finkelstein","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2019041118371705300_B44","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/carcin\/bgm094","article-title":"The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells","volume":"28","author":"Aguilera","year":"2007","journal-title":"Carcinogenesis"},{"issue":"41","key":"2019041118371705300_B45","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M000074200","article-title":"Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells","volume":"275","author":"Haertel-Wiesmann","year":"2000","journal-title":"J Biol Chem"},{"issue":"19","key":"2019041118371705300_B46","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041118371705300_B47","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology","volume":"3","author":"Clarke","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2019041118371705300_B48","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1210\/jc.2013-4440","article-title":"Two years of denosumab and teriparatide administration in postmenopausal women with osteoporosis (the DATA Extension study): a randomized controlled trial","volume":"99","author":"Leder","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/4\/1302\/24565510\/jc.2017-00283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T13:30:01Z","timestamp":1570627801000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/4\/1302\/4819314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,1,22]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-00283","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,1,22]]}}}